UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy

JNCI : Journal of the National Cancer Institute, 2015-04, Vol.107 (4), p.1

2015

Volltextzugriff (PDF)

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

PloS one, 2018-07, Vol.13 (7), p.e0201314-e0201314

2018

Volltextzugriff (PDF)

Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (4), p.1517-1526

2009

Volltextzugriff (PDF)

New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies

Biochemistry Research International, 2011-01, Vol.2011, p.191670-11

2011

Volltextzugriff (PDF)

Sialyl-Tn serves as a potential therapeutic target for ovarian cancer

Journal of ovarian research, 2024-04, Vol.17 (1), p.71-16, Article 71

2024

Volltextzugriff (PDF)

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau

Oncotarget, 2018-05, Vol.9 (33), p.23289-23305

2018

Volltextzugriff (PDF)

A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo

Molecular cancer therapeutics, 2010-06, Vol.9 (6), p.1809-1819

2010

Volltextzugriff (PDF)

Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade

Arthritis & rheumatology (Hoboken, N.J.), 2016-02, Vol.68 (2), p.521-531

2016

Volltextzugriff (PDF)

PEGylated DX-1000: Pharmacokinetics and Antineoplastic Activity of a Specific Plasmin Inhibitor

Neoplasia (New York, N.Y.), 2007-11, Vol.9 (11), p.927-937

2007

Volltextzugriff (PDF)

Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing

Cancer Immunology, Immunotherapy, 2018-09, Vol.67 (9), p.1437-1447

2018

Volltextzugriff (PDF)

CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time

International journal of molecular sciences, 2017-05, Vol.18 (5), p.1047

2017

Volltextzugriff (PDF)

The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival

Oncotarget, 2018-05, Vol.9 (38), p.24992-25007

2018

Volltextzugriff (PDF)

PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways

Journal of applied physiology (1985), 2001-10, Vol.91 (4), p.1819-1827

2001

Volltextzugriff (PDF)

Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1

Journal of leukocyte biology, 2006-10, Vol.80 (4), p.905-914

2006

Volltextzugriff (PDF)

Ezrin is a cyclic AMP-dependent protein kinase anchoring protein

The EMBO journal, 1997-01, Vol.16 (1), p.35-43

1997

Volltextzugriff (PDF)

8-Cl-Adenosine Induces Growth Arrest without Differentiation of Primary Mouse Epidermal Keratinocytes

Journal of investigative dermatology, 2001-12, Vol.117 (6), p.1588-1593

2001

Volltextzugriff (PDF)

8-Cl-Adenosine-Induced Inhibition of Colorectal Cancer Growth In Vitro and In Vivo

Neoplasia (New York, N.Y.), 2000-09, Vol.2 (5), p.441-448

2000

Volltextzugriff (PDF)

Implementing a CTC-based clinical trial assay for selecting AR-V7+ patients for enrollment in a pivotal phase 3 study (ARMOR3-SV)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.348-348

2016

Volltextzugriff (PDF)

AKAP350, a Multiply Spliced Protein Kinase A-anchoring Protein Associated with Centrosomes

The Journal of biological chemistry, 1999-01, Vol.274 (5), p.3055-3066

1999

Volltextzugriff (PDF)

Protein Kinase A Regulatory Subunits in Colon Cancer

Neoplasia (New York, N.Y.), 1999-10, Vol.1 (4), p.373-378

1999

Volltextzugriff (PDF)

Synthesis and Antitumor Activity of Thieno-Separated Tricyclic Purines

Journal of medicinal chemistry, 2000-12, Vol.43 (25), p.4877-4883

2000

Volltextzugriff (PDF)

Abstract B011: Synergistic activity of tazemetostat in combination with androgen signaling inhibitors in preclinical models of prostate cancer demonstrates potential for clinical expansion

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.B011-B011

2019

Volltextzugriff (PDF)

Abstract 1161: EZH2 inhibitor tazemetostat demonstrates activity in preclinical models of Bruton's tyrosine kinase inhibitor-resistant relapsed/refractory mantle cell lymphoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1161-1161

2021

Volltextzugriff (PDF)

Abstract 1234: Galeterone-induced degradation of the androgen receptor involves inhibition of deubiquitinating enzymes

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1234-1234

2016

Volltextzugriff (PDF)

Discovery of human antibodies against the C5aR target using phage display technology

Journal of molecular recognition, 2005-07, Vol.18 (4), p.327-333

2005

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(114)
Japanisch
(19)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis

New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies

Sialyl-Tn serves as a potential therapeutic target for ovarian cancer

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau

A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo

Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade

PEGylated DX-1000: Pharmacokinetics and Antineoplastic Activity of a Specific Plasmin Inhibitor

Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing

CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time

The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival

PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways

Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1

Ezrin is a cyclic AMP-dependent protein kinase anchoring protein

8-Cl-Adenosine Induces Growth Arrest without Differentiation of Primary Mouse Epidermal Keratinocytes

8-Cl-Adenosine-Induced Inhibition of Colorectal Cancer Growth In Vitro and In Vivo

Implementing a CTC-based clinical trial assay for selecting AR-V7+ patients for enrollment in a pivotal phase 3 study (ARMOR3-SV)

AKAP350, a Multiply Spliced Protein Kinase A-anchoring Protein Associated with Centrosomes

Protein Kinase A Regulatory Subunits in Colon Cancer

Synthesis and Antitumor Activity of Thieno-Separated Tricyclic Purines

Abstract B011: Synergistic activity of tazemetostat in combination with androgen signaling inhibitors in preclinical models of prostate cancer demonstrates potential for clinical expansion

Abstract 1161: EZH2 inhibitor tazemetostat demonstrates activity in preclinical models of Bruton's tyrosine kinase inhibitor-resistant relapsed/refractory mantle cell lymphoma

Abstract 1234: Galeterone-induced degradation of the androgen receptor involves inhibition of deubiquitinating enzymes

Discovery of human antibodies against the C5aR target using phage display technology

Suchergebnisse filtern